Expertise in
3
conditions

Dr. Marina Caskey

Infectious Disease
Weill Cornell Medicine - Infectious Diseases
1315 York Ave, 
New York, NY 
Expertise in
3
conditions
Weill Cornell Medicine - Infectious Diseases
1315 York Ave, 
New York, NY 

Overview

Marina Caskey is an Infectious Disease provider in New York, New York. Dr. Caskey is highly rated in 3 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Sepsis, and Pneumonia.

Her clinical research consists of co-authoring 123 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Infectious Disease

Licenses

Internal Medicine in NY

Hospital Affiliations

New York-Presbyterian Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Weill Cornell Medicine - Infectious Diseases
1315 York Ave, New York, NY 10021

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Open Label, Randomized Study of the Safety and Antiretroviral Activity of 3BNC117 and 10-1074 in HIV-infected Individuals on Combination Antiretroviral Therapy and During Analytical Treatment Interruption.
An Open Label, Randomized Study of the Safety and Antiretroviral Activity of 3BNC117 and 10-1074 in HIV-infected Individuals on Combination Antiretroviral Therapy and During Analytical Treatment Interruption.
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Other, Drug
Study Drugs: 3BNC117, 10-1074
Study Phase: Phase 1
An Open Label, Single Arm Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals.
An Open Label, Single Arm Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals.
Enrollment Status: Completed
Publish Date: June 26, 2023
Intervention Type: Drug
Study Drugs: 3BNC117-LS, 10-1074-LS
Study Phase: Phase 1
A Phase 2a, Randomized Study of Romidepsin With or Without 3BNC117 to Evaluate the Effects on the HIV-1 Reservoir (ROADMAP)
A Phase 2a, Randomized Study of Romidepsin With or Without 3BNC117 to Evaluate the Effects on the HIV-1 Reservoir (ROADMAP)
Enrollment Status: Completed
Publish Date: July 14, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Dose Escalation, First-in-human Study of the Safety and Pharmacokinetics of the Subcutaneous and Intravenous Administration of 10-1074-LS Alone and in Combination With 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
A Phase 1, Dose Escalation, First-in-human Study of the Safety and Pharmacokinetics of the Subcutaneous and Intravenous Administration of 10-1074-LS Alone and in Combination With 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
Enrollment Status: Completed
Publish Date: August 04, 2021
Intervention Type: Drug
Study Drugs: 10-1074-LS, 3BNC117-LS
Study Phase: Phase 1
A Phase 1 First-in-human Study of the Safety and Pharmacokinetics of 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
A Phase 1 First-in-human Study of the Safety and Pharmacokinetics of 3BNC117-LS in HIV-infected and HIV-uninfected Individuals
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
An Phase 1b Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117 and 10-1074 in HIV-infected Individuals
An Phase 1b Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117 and 10-1074 in HIV-infected Individuals
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Other, Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

123 Total Publications

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Keith Sigel
Infectious Disease
Expertise in
10
conditions
Dr. Keith Sigel
Infectious Disease

St. Luke's-Roosevelt Hospital Center

158 W 124th St, 
New York, NY 
 (3.2 miles away)
332-243-0100
Languages Spoken:
English
See accepted insurances

Keith Sigel is a primary care provider, practicing in Infectious Disease in New York, New York. Dr. Sigel is highly rated in 10 conditions, according to our data. His top areas of expertise are Anal Cancer, HIV/AIDS, Lung Cancer, Gastrostomy, and Endoscopy.

Expertise in
12
conditions
Dr. Jihad Slim
Infectious Disease
Expertise in
12
conditions
Dr. Jihad Slim
Infectious Disease

Saint Michael's Medical Center

111 Central Ave, 
Newark, NJ 
 (11.6 miles away)
973-877-5644
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jihad Slim is an Infectious Disease provider in Newark, New Jersey. Dr. Slim is highly rated in 12 conditions, according to our data. His top areas of expertise are HIV/AIDS, Hepatitis C, COVID-19, Hepatitis, and Gastrostomy.

Genovefa Papanicolaou
Expertise in
6
conditions
Dr. Genovefa Papanicolaou
Infectious Disease
Expertise in
6
conditions
Dr. Genovefa Papanicolaou
Infectious Disease

David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center

530 E 74th St, 
New York, NY 
 (0.2 miles away)
929-476-0294
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Genovefa Papanicolaou is an Infectious Disease provider in New York, New York. Dr. Papanicolaou is highly rated in 6 conditions, according to our data. Her top areas of expertise are Cytomegalovirus Infection, Sepsis, Cytomegalic Inclusion Disease, and Pneumonia.

Frequently Asked Questions about Dr. Marina Caskey

How do I make an appointment with Dr. Marina Caskey?

You can book an appointment with Dr. Marina Caskey by calling their office at 347-719-7640. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marina Caskey a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marina Caskey is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marina Caskey specialize in?

While Dr. Marina Caskey is a Infectious Disease, they have specific expertise in HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), and Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Marina Caskey participate in research or clinical trials?

Yes. Dr. Marina Caskey has published 123 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Marina Caskey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marina Caskey accept my insurance?

Dr. Marina Caskey accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 347-719-7640 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Caskey's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile